It can be taken orally or applied transdermally for targeted effects
To arrange a consultation with our medical director or for more information on our Intracellular Glutathione Therapy, please call 020 3095 0002 to speak to one of the team.
Peptides are not currently part of standard Australian surgical recovery pathways for knee procedures
For type 2 diabetes , NICE guideline NG28 recommends GLP-1 receptor agonists in specific circumstances, including: As part of triple therapy (with metformin and either a sulfonylurea or pioglitazone) when dual therapy with metformin and another oral drug has not achieved adequate glycaemic control As part of triple therapy with metformin and a sodium-glucose cotransporter 2 (SGLT2) inhibitor if certain criteria are met In combination with insulin, with or without other antidiabetic drugs Treatment should be continued only if there is a beneficial metabolic response (reduction of at least 11 mmol/mol in HbA1c and weight loss of at least 3% at 6 months)
Mild nausea, digestive changes, or appetite fluctuations are common during dose escalation of GLP-1 therapies and can often be managed with titration adjustments, hydration strategies, or meal pacing guidance
By naturally encouraging release of hGH, there are several health benefits that are associated with GAC supplementation